Table 3.
Incidence rate (95% CI)/1000 person-years according to statin use and age
| Any statin use |
No statin use |
|||||
|---|---|---|---|---|---|---|
| VTE | DVT | PE | VTE | DVT | PE | |
| Age (years) | ||||||
| ≤50 | 7.4 (5.9 to 9.1) | 4.6 (3.5 to 6.1) | 3.5 (2.6 to 4.8) | 46.8 (45.8 to 47.8) | 28.6 (27.9 to 29.4) | 19.3 (18.7 to 20.0) |
| 51–60 | 29.8 (25.4 to 34.9) | 17.5 (14.3 to 21.3) | 11.8 (9.3 to 14.9) | 44.8 (43.8 to 45.8) | 27.5 (26.7 to 28.3) | 18.6 (18.0 to 19.2) |
| 61–70 | 30.4 (26.7 to 34.5) | 16.4 (13.9 to 19.4) | 13.9 (11.6 to 16.7) | 45.0 (44.0 to 46.0) | 27.7 (27.0 to 28.5) | 18.6 (18.0 to 19.2) |
| 71–80 | 36.6 (32.1 to 41.8) | 16.2 (13.3 to 19.6) | 21.3 (18.0 to 25.2) | 44.6 (43.6 to 45.6) | 27.6 (26.8 to 28.4) | 18.3 (17.7 to 18.9) |
| >80 | 52.2 (42.1 to 64.8) | 19.7 (14.0 to 27.7) | 33.1 (25.4 to 43.1) | 44.3 (43.3 to 45.2) | 27.3 (26.5 to 28.0) | 18.2 (17.7 to 18.8) |
| All | 24.4 (22.8 to 26.2) | 12.7 (11.5 to 13.9) | 12.3 (11.1 to 13.5) | 48.5 (47.4 to 49.7) | 30.3 (29.4 to 31.1) | 19.6 (19.0 to 20.3) |
DVT, deep venous thrombosis; PE, pulmonary embolism; VTE, venous thromboembolism.